125 related articles for article (PubMed ID: 28445934)
21. Silibinin inhibits β-catenin/ZEB1 signaling and suppresses bladder cancer metastasis via dual-blocking epithelial-mesenchymal transition and stemness.
Wu K; Ning Z; Zeng J; Fan J; Zhou J; Zhang T; Zhang L; Chen Y; Gao Y; Wang B; Guo P; Li L; Wang X; He D
Cell Signal; 2013 Dec; 25(12):2625-33. PubMed ID: 24012496
[TBL] [Abstract][Full Text] [Related]
22. Functional and molecular characterization of cancer stem-like cells in bladder cancer: a potential signature for muscle-invasive tumors.
Ferreira-Teixeira M; Parada B; Rodrigues-Santos P; Alves V; Ramalho JS; Caramelo F; Sousa V; Reis F; Gomes CM
Oncotarget; 2015 Nov; 6(34):36185-201. PubMed ID: 26452033
[TBL] [Abstract][Full Text] [Related]
23. EZH2 in Bladder Cancer, a Promising Therapeutic Target.
Martínez-Fernández M; Rubio C; Segovia C; López-Calderón FF; Dueñas M; Paramio JM
Int J Mol Sci; 2015 Nov; 16(11):27107-32. PubMed ID: 26580594
[TBL] [Abstract][Full Text] [Related]
24. Down-regulating ribonuclease inhibitor enhances metastasis of bladder cancer cells through regulating epithelial-mesenchymal transition and ILK signaling pathway.
Xiong D; Liou Y; Shu J; Li D; Zhang L; Chen J
Exp Mol Pathol; 2014 Jun; 96(3):411-21. PubMed ID: 24768914
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical analysis of the role and relationship between Notch-1 and Oct-4 expression in urinary bladder carcinoma.
Abdou AG; El-Wahed MM; Kandil MA; Samaka RM; Elkady N
APMIS; 2013 Oct; 121(10):982-96. PubMed ID: 23594289
[TBL] [Abstract][Full Text] [Related]
26. Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells.
Alberti L; Losi L; Leyvraz S; Benhattar J
PLoS One; 2015; 10(7):e0132977. PubMed ID: 26185996
[TBL] [Abstract][Full Text] [Related]
27. Regulator of cullins-1 expression knockdown suppresses the malignant progression of muscle-invasive transitional cell carcinoma by regulating mTOR/DEPTOR pathway.
Wang W; Chen H; Liu Z; Qu P; Lan J; Chen H; Zou L; Qiu J
Br J Cancer; 2016 Feb; 114(3):305-13. PubMed ID: 26742010
[TBL] [Abstract][Full Text] [Related]
28. Sox4 Expression Confers Bladder Cancer Stem Cell Properties and Predicts for Poor Patient Outcome.
Shen H; Blijlevens M; Yang N; Frangou C; Wilson KE; Xu B; Zhang Y; Zhang L; Morrison CD; Shepherd L; Hu Q; Zhu Q; Wang J; Liu S; Zhang J
Int J Biol Sci; 2015; 11(12):1363-75. PubMed ID: 26681916
[TBL] [Abstract][Full Text] [Related]
29. Proteolysis-a characteristic of tumor-initiating cells in murine metastatic breast cancer.
Hillebrand LE; Bengsch F; Hochrein J; Hülsdünker J; Bender J; Follo M; Busch H; Boerries M; Reinheckel T
Oncotarget; 2016 Sep; 7(36):58244-58260. PubMed ID: 27542270
[TBL] [Abstract][Full Text] [Related]
30. Mel-18 controls the enrichment of tumor-initiating cells in SP fraction in mouse breast cancer.
Janakiraman H; Nobukiyo A; Inoue H; Kanno M
Hiroshima J Med Sci; 2011 Jun; 60(2):25-35. PubMed ID: 21970185
[TBL] [Abstract][Full Text] [Related]
31. Cancer stem-like cells contribute to cisplatin resistance and progression in bladder cancer.
Zhang Y; Wang Z; Yu J; Shi Jz; Wang C; Fu Wh; Chen Zw; Yang J
Cancer Lett; 2012 Sep; 322(1):70-7. PubMed ID: 22343321
[TBL] [Abstract][Full Text] [Related]
32. Jarid2 promotes temporal progression of retinal progenitors via repression of Foxp1.
Zhang J; Roberts JM; Chang F; Schwakopf J; Vetter ML
Cell Rep; 2023 Mar; 42(3):112237. PubMed ID: 36924502
[TBL] [Abstract][Full Text] [Related]
33. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
[TBL] [Abstract][Full Text] [Related]
34. A novel role of Id-1 in regulation of epithelial-to-mesenchymal transition in bladder cancer.
Hu H; Wang YL; Wang GW; Wong YC; Wang XF; Wang Y; Xu KX
Urol Oncol; 2013 Oct; 31(7):1242-53. PubMed ID: 22226665
[TBL] [Abstract][Full Text] [Related]
35. Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development.
Wu K; Zeng J; Zhou J; Fan J; Chen Y; Wang Z; Zhang T; Wang X; He D
Urol Oncol; 2013 Nov; 31(8):1751-60. PubMed ID: 22421353
[TBL] [Abstract][Full Text] [Related]
36. Epithelial plasticity, cancer stem cells, and the tumor-supportive stroma in bladder carcinoma.
van der Horst G; Bos L; van der Pluijm G
Mol Cancer Res; 2012 Aug; 10(8):995-1009. PubMed ID: 22714124
[TBL] [Abstract][Full Text] [Related]
37. JAK-mediated autophagy regulates stemness and cell survival in cisplatin resistant bladder cancer cells.
Ojha R; Singh SK; Bhattacharyya S
Biochim Biophys Acta; 2016 Nov; 1860(11 Pt A):2484-2497. PubMed ID: 27474203
[TBL] [Abstract][Full Text] [Related]
38. Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression.
Luo M; Li Z; Wang W; Zeng Y; Liu Z; Qiu J
Cancer Lett; 2013 Jun; 333(2):213-21. PubMed ID: 23354591
[TBL] [Abstract][Full Text] [Related]
39. Emerging Roles of Cancer Stem Cells in Bladder Cancer Progression, Tumorigenesis, and Resistance to Chemotherapy: A Potential Therapeutic Target for Bladder Cancer.
Abugomaa A; Elbadawy M; Yamawaki H; Usui T; Sasaki K
Cells; 2020 Jan; 9(1):. PubMed ID: 31963556
[TBL] [Abstract][Full Text] [Related]
40. A novel role of ribonuclease inhibitor in regulation of epithelial-to-mesenchymal transition and ILK signaling pathway in bladder cancer cells.
Yao X; Li D; Xiong DM; Li L; Jiang R; Chen JX
Cell Tissue Res; 2013 Sep; 353(3):409-23. PubMed ID: 23703635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]